MTOR and systemic lupus erythematosus: Given its role in inflammatory processes, mTOR inhibitors are being developed to treat autoimmune degenerative diseases, such as systemic lupus erythematosus (SLE) [107], but also obesity, and to improve cardiovascular health [108].